NO20043313L - Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner - Google Patents
Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjonerInfo
- Publication number
- NO20043313L NO20043313L NO20043313A NO20043313A NO20043313L NO 20043313 L NO20043313 L NO 20043313L NO 20043313 A NO20043313 A NO 20043313A NO 20043313 A NO20043313 A NO 20043313A NO 20043313 L NO20043313 L NO 20043313L
- Authority
- NO
- Norway
- Prior art keywords
- cox
- inhibitors
- treatment
- combination
- antiviral agents
- Prior art date
Links
- 208000009608 Papillomavirus Infections Diseases 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940111134 coxibs Drugs 0.000 title 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/027—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34755002P | 2002-01-10 | 2002-01-10 | |
| PCT/US2003/000016 WO2003059347A1 (en) | 2002-01-10 | 2003-01-10 | Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043313L true NO20043313L (no) | 2004-10-08 |
Family
ID=23364195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043313A NO20043313L (no) | 2002-01-10 | 2004-11-04 | Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030211163A1 (no) |
| EP (1) | EP1463500A1 (no) |
| JP (1) | JP2005519061A (no) |
| KR (1) | KR20040072720A (no) |
| CN (1) | CN1697654A (no) |
| AU (1) | AU2003201811A1 (no) |
| BR (1) | BR0306820A (no) |
| CA (1) | CA2472459A1 (no) |
| CO (1) | CO5590913A2 (no) |
| IL (1) | IL162726A0 (no) |
| MX (1) | MXPA04006572A (no) |
| NO (1) | NO20043313L (no) |
| PL (1) | PL371252A1 (no) |
| RU (1) | RU2004121147A (no) |
| WO (1) | WO2003059347A1 (no) |
| ZA (1) | ZA200404881B (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2277854T5 (es) | 1999-08-25 | 2011-02-04 | Allergan, Inc. | Neurotoxinas recombinantes activables. |
| US7740868B2 (en) | 1999-08-25 | 2010-06-22 | Allergan, Inc. | Activatable clostridial toxins |
| WO2003101438A1 (en) * | 2002-05-30 | 2003-12-11 | Pharmacia & Upjohn Company | Treatment for human papillomavirus |
| CN1726018A (zh) * | 2002-12-19 | 2006-01-25 | 法玛西雅公司 | 使用环加氧酶－2选择性抑制剂或环加氧酶－2抑制剂联合抗病毒剂治疗疱疹病毒感染的方法和组合物 |
| JP2007513165A (ja) | 2003-12-02 | 2007-05-24 | スリーエム イノベイティブ プロパティズ カンパニー | Ｉｒｍ化合物を含む併用薬および治療方法 |
| US20100009928A1 (en) | 2004-03-29 | 2010-01-14 | Cheng Jin Q | Compositions including triciribine and taxanes and methods of use thereof |
| US8080560B2 (en) * | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
| PE20061303A1 (es) * | 2005-03-30 | 2006-12-07 | Astion Dev As | Composicion farmaceutica que comprende oxaprozina |
| US8609623B2 (en) * | 2005-05-18 | 2013-12-17 | Alt Solutions Inc. | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| KR100644968B1 (ko) * | 2005-10-28 | 2006-11-14 | 한국과학기술연구원 | 생체적합성 실리콘 나노입자의 제조 방법 |
| WO2008036858A2 (en) | 2006-09-20 | 2008-03-27 | The Board Of Regents Of The University Of Texas System | Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
| ITRM20080027A1 (it) * | 2008-01-18 | 2009-07-19 | Maria Balestrieri | Uso di aciclovir per il trattamento delle condilomatosi. |
| CN102014961B (zh) | 2008-01-22 | 2017-10-13 | 得克萨斯大学体系董事会 | 用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物 |
| WO2009129094A2 (en) * | 2008-04-15 | 2009-10-22 | Mallinckrodt Inc. | Compositions containing antiviral compounds and methods of using the same |
| IL192335A0 (en) * | 2008-06-19 | 2011-08-01 | Avivi Easy Life Ltd | Antiviral compounds |
| US20110218241A1 (en) * | 2010-03-06 | 2011-09-08 | Cacao Bio-Technologies, Llc | Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
| JP2012020991A (ja) * | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
| WO2013119710A1 (en) | 2012-02-06 | 2013-08-15 | Pridgen William L | Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib |
| TWI646091B (zh) * | 2012-12-28 | 2019-01-01 | 日商衛斯克慧特股份有限公司 | 鹽類及晶形 |
| WO2016036588A1 (en) * | 2014-09-03 | 2016-03-10 | Merck Sharp & Dohme Corp. | Pharmaceutical suspensions containing etoricoxib |
| CN105906496A (zh) * | 2016-05-16 | 2016-08-31 | 苏州毕诺佳医药技术有限公司 | 一种阿昔洛韦的药物组合物及其医药用途 |
| JP7414981B2 (ja) * | 2020-12-28 | 2024-01-16 | 中以海▲徳▼人工智能▲薬▼物研▲発▼股▲ふん▼有限公司 | ウイルス性肝炎を治療又は予防するための薬物組成物及びその応用 |
| WO2022245950A1 (en) * | 2021-05-19 | 2022-11-24 | University Of Miami | Treatment of infections in and around the eye |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6114314A (en) * | 1992-02-21 | 2000-09-05 | Hyal Pharmaceutical Corp. | Formulations containing hyaluronic acid |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
| ES2311571T3 (es) * | 1996-04-12 | 2009-02-16 | G.D. Searle Llc | Derivados de bencenosulfonamida sustituidos como profarmacos de inhibidores de cox-2. |
| GB9615867D0 (en) * | 1996-07-03 | 1996-09-11 | Merck & Co Inc | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
| US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
| US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
| WO1999030721A1 (en) * | 1997-12-17 | 1999-06-24 | Cornell Research Foundation, Inc. | Cyclooxygenase-2 inhibition |
| CA2368593A1 (en) * | 1999-05-14 | 2000-11-23 | Regents Of The University Of California | Anti-inflammatory therapy for inflammatory mediated infection |
| US20030004143A1 (en) * | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the female reproductive tract |
| US20030004142A1 (en) * | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
-
2003
- 2003-01-10 JP JP2003559509A patent/JP2005519061A/ja active Pending
- 2003-01-10 WO PCT/US2003/000016 patent/WO2003059347A1/en not_active Application Discontinuation
- 2003-01-10 BR BR0306820-0A patent/BR0306820A/pt not_active IP Right Cessation
- 2003-01-10 CA CA002472459A patent/CA2472459A1/en not_active Abandoned
- 2003-01-10 IL IL16272603A patent/IL162726A0/xx unknown
- 2003-01-10 EP EP03700670A patent/EP1463500A1/en not_active Withdrawn
- 2003-01-10 AU AU2003201811A patent/AU2003201811A1/en not_active Abandoned
- 2003-01-10 KR KR10-2004-7010785A patent/KR20040072720A/ko not_active Application Discontinuation
- 2003-01-10 PL PL03371252A patent/PL371252A1/xx not_active Application Discontinuation
- 2003-01-10 US US10/339,906 patent/US20030211163A1/en not_active Abandoned
- 2003-01-10 RU RU2004121147/14A patent/RU2004121147A/ru not_active Application Discontinuation
- 2003-01-10 CN CNA038057212A patent/CN1697654A/zh active Pending
- 2003-01-10 MX MXPA04006572A patent/MXPA04006572A/es not_active Application Discontinuation
-
2004
- 2004-06-21 ZA ZA200404881A patent/ZA200404881B/en unknown
- 2004-07-08 CO CO04064572A patent/CO5590913A2/es not_active Application Discontinuation
- 2004-11-04 NO NO20043313A patent/NO20043313L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1463500A1 (en) | 2004-10-06 |
| CA2472459A1 (en) | 2003-07-24 |
| ZA200404881B (en) | 2005-08-31 |
| IL162726A0 (en) | 2005-11-20 |
| US20030211163A1 (en) | 2003-11-13 |
| CO5590913A2 (es) | 2005-12-30 |
| KR20040072720A (ko) | 2004-08-18 |
| JP2005519061A (ja) | 2005-06-30 |
| AU2003201811A1 (en) | 2003-07-30 |
| CN1697654A (zh) | 2005-11-16 |
| BR0306820A (pt) | 2004-12-07 |
| PL371252A1 (en) | 2005-06-13 |
| RU2004121147A (ru) | 2005-04-10 |
| MXPA04006572A (es) | 2005-11-04 |
| WO2003059347A1 (en) | 2003-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043313L (no) | Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner | |
| DK1610770T3 (da) | Anvendelse af en IBAT-inhibitor til behandling eller profylakse af forstoppelse | |
| EE05516B1 (et) | Indasoolid bensotiasoolid ja bensoisotiasoolid nende valmistamine ning kasutamine | |
| EE05507B1 (et) | Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks | |
| CY2013043I1 (el) | Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv | |
| CY2014031I1 (el) | Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae | |
| DK1554518T3 (da) | Gevindskåret rör med overfladebehandling | |
| NO20044054L (no) | Administrering av midler for behandling av betennelse | |
| NO20053782D0 (no) | Behandling av kreft med 2-deoksyglukose | |
| PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
| FI20021144A (fi) | Menetelmä suuntaajasiltojen yhteydessä | |
| IS6918A (is) | Meðferð erfiðra æxla með notkun epóþílon afleiða | |
| EP1765330A4 (en) | PYRANOINDOLE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF DISEASE OR INFECTION CAUSED BY HEPATITIS C VIRUS | |
| DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
| HRP20090513T1 (en) | S-mirtazapine for the treatment of hot flush | |
| EE200300473A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
| EE200300474A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
| FI20010557A0 (fi) | Menetelmä vaihtosuuntaajan yhteydessä | |
| PL377427A1 (pl) | Sposoby i kompozycje do leczenia infekcji wirusem opryszczki z zastosowaniem inhibitorów selektywnych względem cyklooksygenazy-2 lub inhibitorów cyklooksygenazy-2 w połączeniu ze środkami przeciwwirusowymi | |
| DE60326190D1 (de) | des Körpers | |
| DK1545553T3 (da) | Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter | |
| DK1565064T3 (da) | Coatingindretning med integreret rengöringsindretning | |
| DK1496918T3 (da) | Anvendelse af natriummetaarsenit til behandling af tumorer | |
| DK1461042T3 (da) | Anvendelse af desoxypeganin til behandling af klinisk depression | |
| NO20025303L (no) | Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen avtumorer assosiert med höye nivåer av glutation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |